協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/01/13 | 1,838 | 1,859 | 1,790 | 1,845 | +39 | +2.2% | 1,879,200 |
2016/01/12 | 1,835 | 1,856 | 1,799 | 1,806 | -72 | -3.8% | 1,904,900 |
2016/01/08 | 1,835 | 1,918 | 1,803 | 1,878 | +6 | +0.3% | 2,990,500 |
2016/01/07 | 1,860 | 1,919 | 1,843 | 1,872 | +16 | +0.9% | 2,069,800 |
2016/01/06 | 1,855 | 1,897 | 1,823 | 1,856 | -1 | -0.1% | 1,188,700 |
2016/01/05 | 1,850 | 1,880 | 1,817 | 1,857 | -14 | -0.7% | 1,509,100 |
2016/01/04 | 1,905 | 1,928 | 1,863 | 1,871 | -44 | -2.3% | 1,389,900 |
2015/12/30 | 1,946 | 1,956 | 1,891 | 1,915 | -31 | -1.6% | 1,055,000 |
2015/12/29 | 1,912 | 1,947 | 1,893 | 1,946 | +51 | +2.7% | 1,062,000 |
2015/12/28 | 1,903 | 1,916 | 1,856 | 1,895 | -8 | -0.4% | 1,317,000 |
2015/12/25 | 1,866 | 1,922 | 1,855 | 1,903 | +53 | +2.9% | 1,784,000 |
2015/12/24 | 1,961 | 1,979 | 1,847 | 1,850 | -229 | -11% | 4,451,000 |
2015/12/22 | 2,092 | 2,100 | 2,072 | 2,079 | -17 | -0.8% | 772,000 |
2015/12/21 | 2,126 | 2,134 | 2,065 | 2,096 | -51 | -2.4% | 1,050,000 |
2015/12/18 | 2,151 | 2,250 | 2,138 | 2,147 | +11 | +0.5% | 1,614,000 |
2015/12/17 | 2,127 | 2,153 | 2,091 | 2,136 | +59 | +2.8% | 1,359,000 |
2015/12/16 | 2,084 | 2,111 | 2,042 | 2,077 | +31 | +1.5% | 1,269,000 |
2015/12/15 | 2,103 | 2,120 | 2,043 | 2,046 | -40 | -1.9% | 1,153,000 |
2015/12/14 | 2,060 | 2,093 | 2,055 | 2,086 | -37 | -1.7% | 1,240,000 |
2015/12/11 | 2,066 | 2,145 | 2,066 | 2,123 | +41 | +2% | 2,454,000 |
2015/12/10 | 2,072 | 2,101 | 2,054 | 2,082 | -20 | -1% | 1,477,000 |
2015/12/09 | 2,144 | 2,150 | 2,096 | 2,102 | -47 | -2.2% | 1,421,000 |
2015/12/08 | 2,198 | 2,206 | 2,136 | 2,149 | -60 | -2.7% | 1,550,000 |
2015/12/07 | 2,215 | 2,225 | 2,205 | 2,209 | +28 | +1.3% | 673,000 |
2015/12/04 | 2,200 | 2,227 | 2,176 | 2,181 | -68 | -3% | 1,233,000 |
2015/12/03 | 2,300 | 2,304 | 2,242 | 2,249 | -44 | -1.9% | 1,473,000 |
2015/12/02 | 2,210 | 2,310 | 2,201 | 2,293 | +77 | +3.5% | 2,526,000 |
2015/12/01 | 2,168 | 2,216 | 2,144 | 2,216 | +47 | +2.2% | 1,689,000 |
2015/11/30 | 2,150 | 2,189 | 2,122 | 2,169 | -9 | -0.4% | 3,773,000 |
2015/11/27 | 2,195 | 2,195 | 2,136 | 2,178 | -20 | -0.9% | 1,640,000 |
2015/11/26 | 2,207 | 2,224 | 2,194 | 2,198 | +1 | ±0% | 993,000 |
2015/11/25 | 2,190 | 2,207 | 2,176 | 2,197 | -3 | -0.1% | 1,318,000 |
2015/11/24 | 2,165 | 2,208 | 2,165 | 2,200 | +29 | +1.3% | 1,529,000 |
2015/11/20 | 2,123 | 2,171 | 2,106 | 2,171 | +29 | +1.4% | 1,857,000 |
2015/11/19 | 2,102 | 2,159 | 2,101 | 2,142 | +70 | +3.4% | 1,579,000 |
2015/11/18 | 2,111 | 2,116 | 2,063 | 2,072 | -13 | -0.6% | 1,276,000 |
2015/11/17 | 2,052 | 2,103 | 2,040 | 2,085 | +57 | +2.8% | 1,814,000 |
2015/11/16 | 2,006 | 2,043 | 1,995 | 2,028 | -14 | -0.7% | 1,592,000 |
2015/11/13 | 2,081 | 2,088 | 2,025 | 2,042 | -63 | -3% | 1,904,000 |
2015/11/12 | 2,079 | 2,125 | 2,070 | 2,105 | +23 | +1.1% | 1,035,000 |
2015/11/11 | 2,071 | 2,118 | 2,068 | 2,082 | -39 | -1.8% | 2,011,000 |
2015/11/10 | 2,073 | 2,124 | 2,061 | 2,121 | +28 | +1.3% | 1,092,000 |
2015/11/09 | 2,081 | 2,103 | 2,066 | 2,093 | +28 | +1.4% | 1,227,000 |
2015/11/06 | 2,038 | 2,072 | 2,017 | 2,065 | +21 | +1% | 1,053,000 |
2015/11/05 | 2,009 | 2,060 | 2,003 | 2,044 | +54 | +2.7% | 1,366,000 |
2015/11/04 | 1,991 | 2,031 | 1,983 | 1,990 | +39 | +2% | 1,226,000 |
2015/11/02 | 1,972 | 1,981 | 1,941 | 1,951 | -51 | -2.5% | 1,340,000 |
2015/10/30 | 1,975 | 2,019 | 1,973 | 2,002 | +10 | +0.5% | 2,156,000 |
2015/10/29 | 2,030 | 2,048 | 1,979 | 1,992 | +2 | +0.1% | 1,375,000 |
2015/10/28 | 1,973 | 2,003 | 1,956 | 1,990 | +37 | +1.9% | 1,960,000 |
2351~
2400
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 263,900円 | -3.5% | -11.3% | 2.27% | 24.24倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 169,200円 | +0.9% | +380.2% | 4.61% | 23.31倍 | 2.00倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 258,000円 | +20.9% | +10.6% | 2.56% | 12.20倍 | 1.61倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 467,600円 | +0.1% | -3.4% | 3.42% | 31.79倍 | 1.57倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 166,100円 | +0.6% | +43.3% | 4.82% | 11.65倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム